Manning & Napier Advisors LLC Makes New Investment in Cuprina Holdings (Cayman) LTD $CUPR

Manning & Napier Advisors LLC purchased a new stake in shares of Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 12,630,867 shares of the company’s stock, valued at approximately $168,748,000. Cuprina Holdings (Cayman) accounts for approximately 2.2% of Manning & Napier Advisors LLC’s investment portfolio, making the stock its 15th biggest holding. Manning & Napier Advisors LLC owned 13.73% of Cuprina Holdings (Cayman) as of its most recent SEC filing.

Cuprina Holdings (Cayman) Price Performance

NASDAQ:CUPR opened at $2.71 on Tuesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.35 and a current ratio of 2.35. Cuprina Holdings has a one year low of $1.76 and a one year high of $19.60. The business has a fifty day moving average price of $4.03 and a 200-day moving average price of $3.25.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded shares of Cuprina Holdings (Cayman) from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.